Medication context
Reports whether listed drugs should be avoided, used with caution, or used as directed.
Pharmacogenomics
Personalise treatment from the genes up.
A next-generation sequencing pharmacogenomics test that connects genetic variation to medication response and dosing guidance.
Discuss this solution ↗identifi / SIGNAL PROFILEGENOMICS → CLINICAL CONTEXT
90+Medications listed by the company
15Drug classes covered
400+Unique alleles considered
WHAT IS PHARMACOGENOMICS?
Genes can shape
drug response.
Pharmacogenomics (PGx) uses genetic information to understand how a person may respond to medicines. identifi PGx Comprehensive uses NGS to report genetic variants, metabolizer status, medication-use categories, and guideline-based dosing recommendations.
The original product page describes potential benefits including fewer trial-and-error choices, improved adherence, and more personalised medication decisions. It presents the test as a once-in-a-lifetime source of information for clinical review.
WHO THE ORIGINAL PAGE HIGHLIGHTS
One test. Many
care questions.
The existing site says the test is relevant for all, especially people in these situations.
01
People receiving treatment in cardiology, oncology, neurology, pain management, gastroenterology, and other specialties
02
People with a history of medication-related adverse events
03
People with a history of poor response to certain medicines
04
People taking a complex medication regimen
05
People undergoing surgery where anaesthetic agents are used
WHAT THE REPORT INDICATES
Clear categories
for review.
The current product page lists 90+ medications, 15 drug classes, 18 CPIC drug responses, and 400+ unique alleles.
01
Medicines to avoid, use with caution, or use as directed
02
Dosing recommendations based on guidelines
03
Genetic variants that affect medicines and metabolizer status
Questions about identifi?pgx@haystackanalytics.in ↗+91 88288 31393 ↗
PRACTICAL BENEFITS
More context for
each prescription.
Dosing guidance
Provides guideline-based dosage recommendations and metabolizer status.
Across specialties
The existing site lists cardiology, oncology, neurology, pain management, and more.
COMMON QUESTIONS
A little more
clarity.
Specifications are stated on HaystackAnalytics' original website. Confirm current availability and clinical use with the team.
What is identifi PGx Comprehensive? +
It is HaystackAnalytics’ NGS-based pharmacogenomics test, designed to show how genetic variants may influence medication response.
What does the report include? +
The existing product page describes medication-use categories, guideline-based dosing recommendations, genetic variants, and metabolizer status.
How many medications are covered? +
HaystackAnalytics states that identifi PGx Comprehensive provides information across more than 90 medications in 15 drug classes.
LET'S MOVE THE FIELD FORWARD
Better answers begin
with a conversation.
Explore how genomics can fit your clinical or laboratory workflow.
Talk to our team ↗